TX-DENTALMONITORING
1.6.2021 12:17:11 CEST | Business Wire | Press release
The company that pioneered the field of virtual orthodontics and has been the market leader since 2014 is revolutionizing the industry once again with the only available AI-based virtual monitoring solution applicable to both aligner and braces treatments of all types and brands.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210601005494/en/
In an industry where a vast majority of practices are mixed users, the DentalMonitoring’s solution now allows dental professionals — whether in private practices or DSOs — to take full control of not only their aligner and but also all their braces cases. As a result DentalMonitoring expands its addressable market by close to 75%, helping more practices scale up their business, become more efficient and deliver an outstanding patient experience.
“Our solution has made yet another major breakthrough, and we are proud to unveil a new suite of functionalities of our platform,” says Philippe Salah, CEO of DentalMonitoring. “Dental professionals can now monitor all their aligner and braces cases independent of brand with the same, highly scalable AI-driven workflow. In addition to monitoring treatment progress, they can now actively define and monitor clinical goals for each patient. This results in more active control, productivity and a new level of safety and confidence for their practice: a real mindset shift for our industry.”
Salah continues: “Doctors now have complete control over all orthodontic treatment and can automatically track inter arch parameters such as the overbite, the overjet, the transverse or class correction of patients or detect the archwire and auxiliaries passivity in addition to the intra arch parameters they were already able to track with our solution. Dental professionals can virtualize and automate all non-clinical procedures and schedule appointments only when needed. At the same time, the patients’ compliance and engagement are improved, thanks to the complete revamping of our highly rated patient app.”
As the demand for remote care technology increases within the dental industry, DentalMonitoring continues to lead the way with its virtual practice solutions designed to engage, convert and monitor patients. Powered by AI and a database of over half a billion patient photographs, the virtual practice solutions are designed to give dental professionals the flexibility and convenience they need to safely address all sorts of orthodontic patient cases and optimize chair time.
About DentalMonitoring:
DentalMonitoring’s promise is to help all dental professionals improve their practice efficiency, optimize orthodontic treatment plans and enhance the patient experience thanks to its virtual practice solutions:
- SmileMate , maximizes lead engagement and patient conversion, with the ability for dental professionals to triage and qualify patients even before they step into the practice.
- DentalMonitoring , its flagship solution, monitors all treatments remotely, from aligners and braces of all brands to retention and hygiene.
DentalMonitoring operates across the United States, Europe and Asia with five offices: in Austin, TX, London, Paris, Hong Kong and Sydney.
To learn more about DentalMonitoring, visit www.dental-monitoring.com
DentalMonitoring, Smilemate and Vision are products designed and manufactured by Dental Monitoring SAS, under the DentalMind® branding for Health Care Professional.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210601005494/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Murata Launches Ultra-Low Power AMR Sensors to Boost Battery Life in Healthcare and Wearables Devices27.4.2026 04:00:00 CEST | Press release
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has commenced mass production of its MRMS166R and MRMS168R anisotropic magnetoresistance (AMR) sensors for healthcare, wearable, and IoT devices. The MRMS166R is the first AMR sensor to combine an average current consumption of 20 nA with operation from a 1.2 V supply, enabling extended battery life in coin cell-powered systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260413296947/en/ [Murata Manufacturing Co., Ltd.] AMR sensor The devices are solid-state magnetic sensors used for switching applications. They detect the presence or absence of a magnetic field and generate an output signal that system logic uses to control functions such as transitions between active and sleep modes. This enables contactless switching without mechanical components, improving reliability, and supporting sealed, miniaturized designs. Automatic switching between active and
Sun Pharma signs Definitive Agreement to Acquire Organon27.4.2026 01:51:00 CEST | Press release
Organon stockholders to receive US$ 14.00 per share in cashThe deal values Organon at EV of US$ 11.75 billionCombined Business leverages complementary portfolios and global scale for sustained long‑term value creation Sun Pharmaceutical Industries Limited(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co. (NYSE: OGN) (“Organon”) today announced that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for US$ 14.00 per share in an all‑cash transaction with an enterprise valuation of US$ 11.75 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426881370/en/ Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, in 2021. Organon has a legacy of deep trust and strong brand equit
Andersen Global udvider sin tilstedeværelse i Afrika med lanceringen af medlemsfirma i Cameroun26.4.2026 20:56:00 CEST | Pressemeddelelse
Andersen Global træder ind på det camerounske marked, idet Phoenix Advisory bliver medlemsfirma og overgår til Andersen-brandet. Andersen in Cameroun er et specialiseret rådgivningsfirma, der leverer strategiske, erhvervsmæssige, finansielle og operationelle rådgivningsydelser til organisationer i forskellige vækstfaser. Firmaet er grundlagt af fagfolk med erfaring fra store internationale organisationer og kombinerer et stærkt lokalt og centralafrikansk funderet kendskab til forretningsmæssige, juridiske og skattemæssige regler med en skræddersyet tilgang, der har til formål at skabe konkrete og målbare resultater for klienterne. "Overgangen til Andersen-brandet afspejler vores engagement i at vokse sammen med vores kunder og imødekomme stadig mere komplekse behov," udtalte administrerende partner Albert Désiré Zang. "Vi tror på, at langsigtet succes skabes gennem tillid, kvalitet og vedvarende support. At blive et medlemsfirma styrker vores evne til at levere gennemtænkte, bæredygtig
PMCOrganometallix Announces Price Increase on All Products24.4.2026 22:55:00 CEST | Press release
Due to significant changes in market conditions, PMC Organometallix, Inc. announces that effective May 1, 2026, or as contracts permit, prices across all product lines globally will increase by 10-25%. This adjustment is driven by sustained cost pressures from key inputs including rising raw material costs and escalating freight and logistics expenses. While the company has been absorbing these increases, the current economic environment brought on by the geopolitical crisis of the Iran conflict requires this adjustment to continue providing the high-quality, consistent materials and supply reliability that customers expect. PMC Organometallix will implement these changes in a transparent, collaborative manner and values your partnership while navigating these economic challenges. Customers with questions or to discuss a specific situation should contact their account representative. About PMC Group PMC Group is a growth-oriented, diversified, global chemicals and plastics company deli
Frankfurt Higher Regional Court upholds BESREMi® arbitral award in favor of AOP Health24.4.2026 18:52:00 CEST | Press release
Today, the Higher Regional Court of Frankfurt upheld the February 20251 partial final ICC arbitral award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its dispute with PharmaEssentia Corp. (“PharmaEssentia”). The ruling confirms the award which found the Taiwanese company to be liable for certain damages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424005227/en/ Portrait Dr. Rudolf Widmann, Founder AOP Health Credit: AOP Health/Daniel Ospelt Dr. Rudolf Widmann, one of the two founders of AOP Health, explains: “We very much welcome the Frankfurt Higher Regional Court’s decision that confirms our position. In the interest of our patients, we are dedicated to maintaining stable and sustainable access to BESREMi® and to responsibly navigating future challenges.” The Product in Dispute The conflict centers around BESREMi® (ropeginterferon alfa-2b), a product launched in 2019 and developed by AOP Health into
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
